The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like A Double KEiBA Win For Bedfont Scientific Totals 4 Business Awards This Year June 29, 2017 M&A Chatter Swirls Over Amgen's $70B Cashpile February 1, 2018 Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs April 10, 2017
